Lemež P.1, 2,Vítek A.2, Michalová K.2, 3, Zemanová Z.3, Lukášová M.2:
Long-term Results of
Treatment of Adult Patients Under 65 Years with De Novo Acute Myeloid Leukemias without
Favorable Karyotypes in the Study ÚHKT-911
|
174 |
Valočik G.1, Rosochová I.1, Kovács L.2:
Effect of ACE Gene polymorphism on Left Ventricular
Function in Patients with Diabetes Type 2
|
181 |
Chlumský J., Charvát J.:
Importance of Assessment of the Distensibility of the Carotid
Artery
|
185 |
Doležal J.1, Vižďa J.1, Čermáková E.2:
Myelotoxicity after 153Samarium-EDTMP Treatment
for Painful Bone Metastases
|
189 |
Payer J.1 jun., Šteňová E.1, Killinger Z.1, Huorka M.1, Kratochvíľová H.1,Ondrejka P.2:
Osseous
Changes in Patients after Partial Gastrectomy
|
194 |
Dastych M. jun.1, Dastych M. sen.2, Zbořil V.1, Šenkyřík M.1, Starý K.1, Čáslavský J.3, Chmelík J.3:
Pitfalls in the Diagnosis of Carcinoid in Patients Treated with Aminosalicylates
|
200 |
Svačinová H.1, Olšovský J.2, Žáčková V.2, Jančík J.1, Placheta Z.1, Siegelová J.1:
Effect Walking
Exercise on the Aerobic Capacity and Blood Lipids in Type 2 Diabetics
|
205 |
Obořilová A.1, Mayer J.1, Pavlík P.2, Buliková A.3, Vorlíček J.1:
Haemophagocytic Syndrome
(Case-report and Review of Literature)
|
210 |
Okša A.1, Dzúrik R.1, Demeš M.2:
Atherosclerotic Nephropathy in Renal Artery Stenosis -
from Randomized Trials to the Individualized Treatment
|
217 |
Olexa P.1, Olexová M.2:
Plasminogen Activator Inhibitor (PAI-1), Ischaemic Heart Disease
and Diabetes Mellitus
|
222 |
Kubešová H.1, Penka M.2:
Specific Features of Haematopoiesis and Haemostasis in Advanced
Age
|
227 |
Krajčík Š.:
Possibilities to Prevent Dementia?
|
234 |
Krupička J.1, Herold M.1, Rychterová V.2, Straka Z.1, Línková H.1:
Protracted Infection of Pacemaker
Leads with Development of Large
Vegetations: Three Years Follow up.
Case Report
|
241 |
Holm F., Paleček T., Linhart A., Řezníček V., Aschermann M.:
Idiopathic Pulmonary
Artery Aneurysm: A Case Report
|
244 |
